Search results for " embolization"
showing 3 items of 33 documents
0197: Angiographically visible distal embolization is not linked with culprit lesion but with clinical characteristics
2016
Despite the recent improvements in percutaneous coronary intervention (PCI), angiographically visible distal embolization (AVDE) complicates 6 to 18% of ST elevation myocardial infarction (STEMI) treated with PCI, and is associated with poor clinical outcomes. Culprit lesion characteristics have been proved to be the main predictive factor of AVDE. But data regarding clinical characteristics predicting AVDE are lacking. We aimed to identify predictors of AVDE complicating PCI in STEMI management. 769 consecutive patients admitted for STEMI who underwent PCI were included. Clinical, angiographic and therapeutics characteristics were assessed for each patien. AVDE was defined as an abrupt ves…
Image-Guided Mini-Invasive Treatments for Vascular and Oncologic Diseases: Embolization Therapy
2020
Transcatheter Embolization, also called Embolotherapy, is a mini-invasive, non-surgical therapeutic solution used in Interventional Radiology to close blood vessels deliberately. A wide range of embolic agents is available in clinical practice, including metal coils and liquid agents. More recent advances in biomaterials such as shape-memory foam and in-situ gelling solutions have led to the development of new pre-clinical embolic agents. This review offers a brief overview of current and emerging technologies in the field of endovascular embolization. The focus is on devices, materials and techniques.
Preoperative hepatic artery embolization before distal pancreatectomy plus celiac axis resection does not improve surgical results: A Spanish multice…
2021
Distal pancreatectomy with celiac axis resection (DP-CAR) is a surgical procedure with high morbidity and mortality performed in patients with locally advanced pancreatic cancer. Preoperative embolization of hepatic artery (PHAE) has been postulated as a technical option to increase resection rate.comparison of morbidity and mortality at 90 days, operative time, hospital stay and survival between patients that performed DP-CAR with and without PHAE.Observational retrospective multicentre study.patient operated in Spanish centers with DP-CAR for pancreatic cancer from April 2004 until 23 June 2018. Preoperative (PHAE, neodjuvant treatment), intraoperative (operative time and blood loss) and …